4th Quarter - Report

KOUNTOUPES DENHAM CARR & REID, LLC for GLENMARK PHARMACEUTICALS, INC., USA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to tax reform.

Foreign entity interest: Glenmark

LobbyistCovered position, as disclosed
DAVID PAUL PELUSO —
MARY R "RANDI" REID —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General education about the generic pharmaceutical industry.

Foreign entity interest: Glenmark

LobbyistCovered position, as disclosed
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to Medicaid CPI Penalty.

Foreign entity interest: Glenmark

LobbyistCovered position, as disclosed
LISA KOUNTOUPES —
DAVID PAUL PELUSO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals.

Foreign entity interest: Glenmark

LobbyistCovered position, as disclosed
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.